CoChat

The enigma of mixed dementia

Jellinger, Kurt A. · 2007 · Alzheimer's & Dementia
Cited by 138

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Mixed type dementia (MD) refers to a combination of Alzheimer disease (AD) and vascular encephalopathy (VE) and other dementia disorders, but the distinction between these diseases is difficult. For the diagnosis of MD, the clinical/neuroimaging criteria of probable AD plus vascular cognitive impairment (VCI) as separate entities are used. Both disorders increase exponentially with age, but their interactions are common and controversial. Pathologic diagnosis is based on the combination of autopsy‐proven AD with multiple vascular or ischemic brain lesions. The population‐based incidence and prevalence of MD is unknown. In retrospective and prospective autopsy studies, its prevalence ranges from 2% to 58% with reasonable means of 6% to 12%, although findings from several recent studies indicated frequent coexistence of AD with multiple cerebrovascular lesions (CVLs) in cognitively impaired elderly subjects. In both AD and VCI, vascular lesions frequently involve subcortical regions (basal ganglia, thalamus, hippocampus, white matter) or are multiple microinfarcts, whereas in MD large/hemispheral infarcts and multiple microinfarcts are more frequent, suggesting different pathogenic mechanisms. There is increasing evidence that critically located small CVLs can induce/promote cognitive impairment in early‐stage AD but not once AD pathology becomes more advanced. Discussion of the major pathogenic factors inducing AD, VCI, and MD suggests synergistic relations between these disorders. Currently available clinical and morphologic criteria for AD and VCI are of limited value for the diagnosis of MD, and the ability of current consensus criteria to distinguish between AD, VCI, and MD is limited. Therefore, future development of methods that more accurately characterize the impact of both AD‐related and vascular brain injuries are warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2006.09.002

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 114

  1. Erkinjuntti T, 2004, Stroke: pathophysiology, diagnosis, and management, 648, 10.1016/B0-44-306600-0/50035-3 · DOI
  2. Bowler JV, 2003, Vascular cognitive impairment: preventable dementia, 1, 10.1093/oso/9780192632678.001.0001 · DOI
  3. Merino JG, 2005, Vascular dementia: cerebrovascular mechanisms and clinical management, 57, 10.1385/1-59259-824-2:057 · DOI
  4. 10.1016/j.jns.2004.11.016 · DOI
  5. 10.3109/9781420016819-12 · DOI
  6. Jellinger KA, 2004, Current clinical neurology: Vascular dementia: cerebrovascular mechanisms and clinical management, 23
  7. 10.1179/016164104225016254 · DOI · Paper page
  8. 10.1016/S1474-4422(04)00683-0 · DOI · Paper page
  9. 10.1097/00002093-199912003-00016 · DOI · Paper page
  10. 10.1179/016164104225017668 · DOI · Paper page
  11. 10.1016/j.jns.2004.11.018 · DOI
  12. 10.1111/j.1600-0404.2006.00665.x · DOI · Paper page
  13. 10.1111/j.1750-3639.2006.tb00559.x · DOI · Paper page
  14. Vinters HV, 2003, Amyloidosis of cerebral arteries, Adv Neurol., 92, 105
  15. 10.1159/000079192 · DOI · Paper page
  16. 10.1097/01.wad.0000167923.56275.d8 · DOI · Paper page
  17. 10.1016/j.tins.2005.02.001 · DOI · Paper page
  18. 10.1161/01.STR.0000014421.15948.67 · DOI · Paper page
  19. 10.1212/01.wnl.0000168863.49053.4d · DOI · Paper page
  20. 10.1212/WNL.45.3.461 · DOI · Paper page
  21. Lewis H, 2006, Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia, Neuropathol Appl Neurobiol., 32, 103, 10.1111/j.1365-2990.2006.00696.x · DOI · Paper page
  22. 10.1111/j.1750-3639.2006.tb00560.x · DOI · Paper page
  23. Weller RO, 2004, Cerebrovascular disease and the pathophysiology of Alzheimer's disease: Implications for therapy, Panminerva Med., 47, 239
  24. 10.1159/000106940 · DOI · Paper page
  25. Crystal H, 2002, Cerebral infarcts in patients with autopsy proven Alzheimer's disease [abstr], Neurobiol Aging., 23, 207
  26. Duyckaerts C, 2003, Neurodegeneration: The molecular pathology of dementia and movement disorders, 47
  27. 10.1097/00019442-199700540-00002 · DOI
  28. American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
  29. World Health Organization, 1993, International classification of diseases
  30. 10.1136/jnnp.53.11.961 · DOI · Paper page
  31. Erkinjuntti T, 2000, Research criteria for subcortical vascular dementia in clinical trials, J Neural Transm (Suppl)., 59, 23
  32. Bowler JV, 2003, Vascular cognitive impairment
  33. 10.1016/j.jalz.2006.04.002 · DOI
  34. Jellinger KA, 2004, Pathology and pathophysiology of vascular cognitive impairment: A critical update, Panminerva Med., 46, 217
  35. Jellinger KA, 2005, Understanding the pathology of vascular cognitive impairment, J Neurol Sci., 229, 57, 10.1016/j.jns.2004.11.029 · DOI
  36. 10.1212/WNL.34.7.939 · DOI · Paper page
  37. 10.1159/000094973 · DOI · Paper page
  38. 10.1176/appi.ajp.159.1.82 · DOI · Paper page
  39. JPBacchetta EKovari MMerlo ACanuto FRHerrmann CBouras et al.Validation of clinical criteria for possible vascular dementia in the oldest-old. Neurobiol Aging2006 Mar 29; [Epub ahead of print]: DOI10.1016/j.neurobiolaging.2006.006. · doi:10.1016/j.neurobiolaging.2006.006
  40. 10.3233/JAD-2006-9S308 · DOI · Paper page
  41. 10.1001/archneur.1987.00520130016010 · DOI · Paper page
  42. Winblad B, 1986, Dimensions in aging, 183
  43. Knopman DS, 2003, Neurodegeneration: The molecular pathology of dementia and movement disorders, 24
  44. 10.1001/archneur.1985.04060100083029 · DOI · Paper page
  45. 10.1097/00005072-198705000-00003 · DOI · Paper page
  46. 10.1212/01.WNL.0000118212.41542.E7 · DOI · Paper page
  47. Jellinger KA, 2003, Neurodegeneration: the molecular pathology of dementia and movement disorders, 66
  48. KAJellinger JAttems.Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol2006 Nov 7; [Epub ahead of print]: DOI10.1007/s00401-006-0156-7. · DOI
  49. Mirra SS, 2002, Greenfield's neuropathology, 195
  50. 10.1097/00002093-199809000-00010 · DOI · Paper page
  51. 10.1212/WNL.42.2.329 · DOI · Paper page
  52. 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
  53. 10.1097/00005072-199107000-00008 · DOI · Paper page
  54. 10.1212/WNL.52.6.1158 · DOI · Paper page
  55. 10.1161/01.STR.0000166052.89772.b5 · DOI · Paper page
  56. Zekry D, 2005, [Mixed dementia: a neuropathologic point of view], Psychol Neuropsychiatr Vieil., 3, 251
  57. 10.1016/S0165-0173(97)00023-4 · DOI · Paper page
  58. 10.1097/00005072-199702000-00007 · DOI · Paper page
  59. Woodward M, 2006, High prevalence of multiple brain pathologies in dementia, Alzheimer's & Dementia., 2, S426
  60. Lobo A, 2000, Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts: Neurologic Diseases in the Elderly Research Group, Neurology., 54, S4
  61. 10.1111/j.1532-5415.2004.52058.x · DOI · Paper page
  62. 10.1212/01.WNL.0000160107.02316.BF · DOI · Paper page
  63. 10.1001/archneur.59.10.1605 · DOI · Paper page
  64. 10.1111/j.1532-5415.1998.tb01076.x · DOI · Paper page
  65. 10.1016/0022-510X(75)90116-1 · DOI
  66. 10.1136/jnnp.48.11.1085 · DOI · Paper page
  67. 10.1007/BF00313858 · DOI
  68. 10.1007/BF00688184 · DOI · Paper page
  69. 10.1002/ana.410240110 · DOI · Paper page
  70. 10.1002/ana.410240306 · DOI · Paper page
  71. 10.1212/WNL.39.1.76 · DOI · Paper page
  72. O'Brien MD, 1994, How does cerebrovascular disease cause dementia?, Dementia, 5, 133
  73. 10.1016/0022-510X(90)90072-U · DOI · Paper page
  74. 10.1159/000106712 · DOI · Paper page
  75. Markesbery WR, 1998, Neuropathology of dementing disorders, 293
  76. 10.1002/ana.10161 · DOI · Paper page
  77. 10.1111/j.1532-5415.1999.tb02571.x · DOI · Paper page
  78. 10.1001/archneur.61.10.1545 · DOI · Paper page
  79. 10.1159/000083801 · DOI · Paper page
  80. 10.1007/s00415-003-0142-0 · DOI
  81. 10.1161/01.STR.0000024523.82311.77 · DOI · Paper page
  82. 10.1001/archneur.1994.00540220045013 · DOI · Paper page
  83. 10.1007/s00401-003-0738-6 · DOI · Paper page
  84. 10.1007/s00401-003-0738-6 · DOI · Paper page
  85. 10.1001/archneur.57.10.1474 · DOI · Paper page
  86. 10.1016/j.jns.2004.08.016 · DOI
  87. 10.1007/s00415-002-0883-1 · DOI
  88. 10.1111/j.1749-6632.2000.tb06347.x · DOI · Paper page
  89. 10.3233/JAD-1998-1205 · DOI · Paper page
  90. 10.1023/B:NERE.0000023612.66691.e6 · DOI
  91. 10.1016/0022-510X(96)00008-1 · DOI
  92. Jellinger KA, 2005, Current clinical neurology: Vascular dementia: cerebrovascular mechanisms and clinical management, 23
  93. Frisoni GB, 2001, Cerebrovascular disease affects noncognitive symptoms in Alzheimer disease, Arch Neurol., 58, 1939, 10.1001/archneur.58.11.1939 · DOI
  94. 10.1016/S0022-510X(02)00282-4 · DOI
  95. Jellinger KA, 2002, Vascular-ischemic dementia: an update, J Neural Transm., 62, 1
  96. 10.1179/016164104225014003 · DOI · Paper page
  97. 10.1007/s00401-006-0054-z · DOI
  98. Thomas A, 2005, Correlation of entorhinal amyloid with memory in Alzheimer's and vascular but not Lewy body dementia, Dement Geriatr Cogn Disord., 19, 57, 10.1159/000082349 · DOI
  99. 10.1111/j.1749-6632.1997.tb48511.x · DOI
  100. 10.1001/archneur.1995.00540310076019 · DOI · Paper page
  101. 10.1002/ana.410010621 · doi:10.1002/ana.410010621
  102. Tian J, 2004, Cerebral amyloid angiopathy and dementia, Panminerva Med., 46, 253
  103. 10.1212/01.wnl.0000223613.57229.24 · DOI · Paper page
  104. 10.1159/000092958 · DOI · Paper page
  105. 10.1002/gps.1550 · DOI · Paper page
  106. 10.1016/j.brainresrev.2004.12.014 · DOI
  107. 10.1136/jnnp.2003.023713 · DOI · Paper page
  108. 10.1016/j.neurobiolaging.2004.05.002 · DOI
  109. 10.1161/01.STR.0000133686.29320.58 · DOI · Paper page
  110. 10.1136/jnnp.2005.064998 · DOI · Paper page
  111. 10.1136/jnnp.2003.019273 · DOI · Paper page
  112. 10.1136/jnnp.2005.070193 · DOI · Paper page
  113. 10.1016/j.jns.2004.09.016 · DOI · Paper page
  114. 10.4065/81.2.223 · DOI

Cited by

See all 138

Metadata

Authors
Jellinger, K. A.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2007-01
Volume
3
Issue
1
Pages
40-53
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2076929722
Cited by
138
References
49
FWCI
2.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.